0001567619-23-007439.txt : 20231012 0001567619-23-007439.hdr.sgml : 20231012 20231012154948 ACCESSION NUMBER: 0001567619-23-007439 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 EFFECTIVENESS DATE: 20231012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CuraSen Therapeutics, Inc. CENTRAL INDEX KEY: 0001765883 IRS NUMBER: 812270808 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-464469 FILM NUMBER: 231322674 BUSINESS ADDRESS: STREET 1: 930 BRITTAN RD., STE. 306 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-475-2842 MAIL ADDRESS: STREET 1: 930 BRITTAN RD., STE. 306 CITY: SAN CARLOS STATE: CA ZIP: 94070 D/A 1 primary_doc.xml X0708 D/A LIVE 0001765883 CuraSen Therapeutics, Inc. 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 (650) 475-2842 DELAWARE None None Corporation true Anthony P. Ford 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 Director Executive Officer Kathleen Sereda Glaub 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 Director Ron Hunt 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 Director Patrick Enright 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 Director Loretta Tse, Ph.D. 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 Director Simon Tate 930 Brittan Rd., Ste. 306 San Carlos CA CALIFORNIA 94070 Director Benjamin Potter Latham & Watkins LLP 140 Scott Drive Menlo Park CA CALIFORNIA 94025 Executive Officer Biotechnology Decline to Disclose 06b true 0001567619-22-019469 2022-11-01 true true false 0 20814709 17599997 3214712 false 11 0 0 0 false CuraSen Therapeutics, Inc. /s/ Anthony P. Ford Anthony P. Ford President and Chief Executive Officer 2023-10-11